The Effect of SHR20004(Noiiglutide ) on Body Weight in Obese Subjects Without Diabetes

NCT04799327 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2022-03-15

No results posted yet for this study

Summary

The study is being conducted to assess the efficacy and safety of SHR20004 on body weight in obese subjects without diabetes.

Conditions

Interventions

DRUG

SHR20004

SHR20004:low dose

DRUG

SHR20004

SHR20004: medium dose

DRUG

SHR20004

SHR20004: high dose

DRUG

placebo

Placebo

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-29
Primary Completion
2022-05-15
Completion
2022-05-15

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04799327 on ClinicalTrials.gov